Baricitinib Adds to Benefit of Steroids in Severe COVID-19 Baricitinib Adds to Benefit of Steroids in Severe COVID-19

Hospitalized COVID-19 patients died less often if they received Eli Lilly ' s rheumatoid arthritis drug baricitinib along with the other treatments their doctors had prescribed, according to a study published in The Lancet Respiratory Medicine.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news